Which post-menopausal metabolic bone disease is characterized by a significant decrease in bone mineral density and increased susceptibility to fractures due to declining estrogen levels?
Answer and explanation
Correct answer: C. Osteoporosis
- Step 1: Bone remodeling involves continuous resorption by osteoclasts and synthesis by osteoblasts.
- Step 2: Estrogen maintains bone mass by promoting osteoclast apoptosis and stimulating osteoblasts.
- Step 3: Following menopause, estrogen levels decline precipitously, shifting the balance toward excessive osteoclastic bone resorption.
- Step 4: This causes thinning of cortical bone and porous trabeculae (decreased bone mass), defining osteoporosis and dramatically elevating the risk of hip, wrist, and vertebral compression fractures.
Answer
Osteoporosis
Why not the others: 'Gouty arthritis' is caused by the deposition of monosodium urate crystals in joint synovial fluid; 'Osteopetrosis' is a rare genetic disorder characterized by overly dense, sclerotic bones due to defective osteoclasts; 'Paget's disease' causes disorganized, deformed bone remodeling with localized bone enlargement.
Practise more Excretory Products, Locomotion and Movement, Neural Control.
Free questions with an explanation for every one, and full timed NEET UG mock tests.
More Excretory Products, Locomotion and Movement, Neural Control questions
- Which group of organisms exhibits uricotelism, excreting nitrogenous waste primarily as relatively insoluble, non-toxic uric acid pellets to…
- In the human nephron, which histological adaptation of the proximal convoluted tubule (PCT) facilitates the reabsorption of 70 to 80 percent…
- In the countercurrent multiplier mechanism of the loop of Henle, what are the distinct permeability characteristics of the descending limb v…
- What triggers the release of the enzyme renin by juxtaglomerular (JG) cells in the kidney?
- How does Antidiuretic Hormone (ADH / Vasopressin), released from the posterior pituitary, promote the formation of concentrated urine?
- Which cardiac hormone acts as a physiological antagonist to the Renin-Angiotensin-Aldosterone System (RAAS) by promoting natriuresis and vas…